Wilson Sonsini Goodrich & Rosati is proud to support Synbiobeta 2020: The Global Synthetic Biology Conference. It is an impactful event that unites the leading biological engineers, investors, innovators, and entrepreneurs who make up this fast-growing industry. The 3-day conference is filled will interactivity packed with exceptional content and delivered entirely online by using the latest technology to keep the event entertaining, engaging and interactive. Day one will feature the annual Investor Grand Panel, show attendees how to build the lab of the future, explore conscious capitalism, and announce inductees in The Biotech Startup Draft. On day 2 they will explore biotech and the brain, anticipate the future of food, go beyond sustainability to a truly circular carbon economy, and consider synthetic biology as a force of equity. Day 3 will focus on new synthetic biology modalities in health care, emerging technology platforms for vaccines, therapies and diagnostics, and the latest COVID developments.